A case of late-onset sustained ventricular tachycardia following deployment of amplatzer-type perimembranous VSD occluder

2013 ◽  
Vol 83 (2) ◽  
pp. 256-260 ◽  
Author(s):  
Kaiyu Zhou ◽  
Yimin Hua ◽  
Lina Qiao
Keyword(s):  
Ventricular Tachycardia ◽  
Late Onset ◽  
Sustained Ventricular Tachycardia

scholarly journals In-hospital outcomes of sustained ventricular tachycardia in the setting of Acute Coronary Syndrome

EP Europace ◽  
2021 ◽  
Vol 23 (Supplement_3) ◽  
Author(s):  
M Santos ◽  
H Santos ◽  
I Almeida ◽  
H Miranda ◽  
C Sa ◽  
...  
Keyword(s):  
Heart Failure ◽  
Atrial Fibrillation ◽  
Logistic Regression ◽  
Ventricular Tachycardia ◽  
Early Onset ◽  
Late Onset ◽  
Sustained Ventricular Tachycardia ◽  
Hospital Death ◽  
Coronary Syndrome ◽  
St Elevation

Abstract Funding Acknowledgements Type of funding sources: None. OnBehalf on behalf of the Investigators of " Portuguese Registry of ACS " Introduction Sustained ventricular tachycardia (SVT) complicates up to 20% of acute coronary syndromes (ACS) and it is, therefore, important to access its impact on prognosis and identify patients with higher risk of SVT. Objective To evaluate predictors of early onset (<48h) and late onset (≥48h) SVT. Methods Based on a multicenter retrospective study, data collected from admissions between 1/10/2010 and 4/09/2019. Patients (pts) were divided in two groups (G): A – pts that presented early onset SVT (ESVT), and B – pts that presented late onset SVT (LSVT). Pts without data on previous cardiovascular history or uncompleted clinical data were excluded. Logistic regression was performed to assess predictors of SVT in ACS. Results Between 29851 pts with ACS, 364 (1.2%) presented SVT. ESVT – 251 pts (69%); LSVT – 91 pts (25%). LSVT G was older (74 ± 13 vs 68 ± 14, p = 0.003), was admitted directly to cat lab less frequently (10.1% vs 24.8%, p = 0.003), had longer times from first symptoms to admission (440min vs 261 min, p < 0.001) and had higher rates of previous stroke (14.4% vs 6.8%, p = 0.028). LSVT G had higher rates of non-ST-elevation myocardial infarction (MI) (35.2% vs 23.1%, p = 0.025) and lower rates of ST-elevation MI (53.8% vs 71.7%, p = 0.002), although both G were similar regarding MI location (anterior – p = 0.135, inferior – p = 0.097). LSVT G had higher systolic blood pression (130 ± 33 vs 122 ± 33, p = 0.050), presented more frequently in Killip-Kimball class ≥2 (52.5% vs 35.5%, p = 0.005) and with atrial fibrillation (21.2% vs 12.4%, p = 0.045), and had higher brain-natriuretic peptide (1075 vs 329, p < 0.001). LSVT G was treated more frequently with diuretics (80.0% vs 47.8%, p < 0.001), amiodarone (62.2% vs 48.8%, p = 0.029), digoxin (8.9% vs 2.4%, p = 0.013) and levosimendan (11.1% vs 2.8%, p = 0.004). ESVT G had higher rates of performed coronarography (88.4% vs 79.1%, p = 0.028) but lower rate of 3 vessels disease (58.5% vs 70.8%, p = 0.017). LSVT G had higher rates of severe (<30%) left ventricle dysfunction (32.9% vs 15.4%, p < 0.001) and need to non-invasive ventilation (23.1% vs 6.8%, p < 0.001). Regarding in-hospital complications, ESVT G had higher rates of heart failure (34.7% vs 19.1%, p = 0.006), atrioventricular block (15.7% vs 1.1%, p < 0.001), atrial fibrillation (20.4% vs 7.7%, p = 0.006) and major haemorrhage (5.2% vs 0.0%, p = 0.024). LSVT G had higher rates of in-hospital death (44.4% vs 20.9%, p < 0.001) and in-hospital stay (14 days vs 7 days, p < 0.001). The G were similar regarding re-infarction (p = 0.216), shock (p = 0.179), mechanical complications (p = 1.00), cardiac arrest (p = 0.097) and stroke (0.348) rates. Logistic regression confirmed ESVT was predictive in-hospital heart failure (p = 0.010, OR 2.67) and de novo AF (p = 0.001, OR 5.56), whether LSVT was predictive of in-hospital death (p = 0.002, OR 2.70). Conclusion LSVT was associated with higher rates of in-hospital complications, but ESVT was associated with higher in-hospital mortality.

Catheter ablation of haemodynamically unstable or non-sustained ventricular tachycardia

2007 ◽  
Vol 62 (2) ◽  
pp. 163-169 ◽  
Author(s):  
S. WU ◽  
W.F. KERWIN ◽  
C.T. PETER ◽  
E.S. GANG ◽  
H. MA
Keyword(s):  
Ventricular Tachycardia ◽  
Catheter Ablation ◽  
Sustained Ventricular Tachycardia

Spatial Features in Body-Surface Potential Maps Can Identify Patients With a History of Sustained Ventricular Tachycardia

Circulation ◽  
1995 ◽  
Vol 92 (7) ◽  
pp. 1825-1838 ◽  
Author(s):  
Cheryl L. Hubley-Kozey ◽  
L. Brent Mitchell ◽  
Martin J. Gardner ◽  
James W. Warren ◽  
Cindy J. Penney ◽  
...  
Keyword(s):  
Ventricular Tachycardia ◽  
Surface Potential ◽  
Body Surface ◽  
Sustained Ventricular Tachycardia ◽  
Spatial Features ◽  
Body Surface Potential Maps ◽  
Body Surface Potential ◽  
History Of

Cardiac calcified amorphous tumor with sustained ventricular tachycardia

2021 ◽  
pp. 021849232110139
Author(s):  
Fumio Yamana ◽  
Keitaro Domae ◽  
Yukitoshi Shirakawa ◽  
Toshiki Takahashi ◽  
Hiroyuki Hao
Keyword(s):  
Computed Tomography ◽  
Ventricular Tachycardia ◽  
Histopathological Examination ◽  
Sustained Ventricular Tachycardia ◽  
Total Removal ◽  
Postoperative Course ◽  
Contrast Enhanced ◽  
Calcified Amorphous Tumor ◽  
Cryo Ablation ◽  
Myocardial Border

Cardiac calcified amorphous tumors are rare non-neoplastic intracavitary masses with unknown cause. A 60-year-old man presented with sustained ventricular tachycardia. Transthoracic echocardiography and contrast-enhanced angio-computed tomography demonstrated an expanding 73 × 40 mm sized calcified mass in the left ventricle. He underwent successful total removal of the mass and cryo-ablation at the normal myocardial border. Histopathological examination confirmed a diagnosis of cardiac calcified amorphous tumors. The postoperative course was uneventful, without ventricular tachycardia recurrence. To our knowledge, this is the first reported case of confirmed cardiac calcified amorphous tumors causing ventricular tachycardia and treated by surgical resection combined with cryo-ablation.

Sustained ventricular tachycardia in a thalidomide-treated patient with primary plasma-cell leukemia

2007 ◽  
Vol 4 (12) ◽  
pp. 722-725 ◽  
Author(s):  
Stelvio Ballanti ◽  
Elena Mastrodicasa ◽  
Niccolò Bolli ◽  
Flavia Lotti ◽  
Ilaria Capolsini ◽  
...  
Keyword(s):  
Ventricular Tachycardia ◽  
Plasma Cell ◽  
Treated Patient ◽  
Sustained Ventricular Tachycardia ◽  
Plasma Cell Leukemia ◽  
Cell Leukemia ◽  
Primary Plasma Cell Leukemia
Sign in / Sign up

Export Citation Format

Share Document